Online ISSN: 1949-2553
www.oncotarget.com
About Oncotarget
Our mission is to make scientific results rapidly and widely available. We seek to maximize the impact of research via insightful review, to enable exceptional discoveries to be shared quickly, to eliminate the border between specialties, to link different fields of biomedical science, and to foster application of basic and clinical science to fight disease.

LEARN MORE ABOUT ONCOTARGET

New Study: Nanoparticles Target Acute Myeloid Leukemia

Oncotarget

September 15, 2021
Researchers developed a nanoparticle-based T cell engager (nanoTCE) technology believed to be capable of targeting any immune cell and cancer of interest. NanoTCE efficacy was examined in acute myeloid leukemia. continue reading »

Table of Contents: Oncotarget’s Volume 12, Issue #19

Oncotarget

September 14, 2021
Read short summaries of the latest oncology-focused research published in this week’s issue of Oncotarget, Volume 12, Issue 19. continue reading »

New Study: How Exercise Boosted Chemotherapy in Mice

Oncotarget

September 1, 2021
A 2021 study demonstrated how exercise impacts a highly-prescribed chemotherapeutic agent, doxorubicin, in murine models of breast cancer. continue reading »

Table of Contents: Oncotarget’s Volume 12, Issue #18

Oncotarget

August 31, 2021
Read short summaries of the latest oncology-focused research published in this week’s issue of Oncotarget, Volume 12, Issue 18. continue reading »

Behind the Study: Oral Squamous Carcinoma Cell Migration and Viability

Oncotarget

August 30, 2021
Dr. Gary S. Goldberg from Rowan University details a 2015 paper he co-authored, entitled, “Antibody and lectin target podoplanin to inhibit oral squamous carcinoma cell migration and viability by distinct mechanisms.” continue reading »